Ryerson University researcher Michael Kolios is developing new breakthroughs in chemotherapy monitoring technology using inexpensive and non-invasive processes to image cancer response to treatment. As part of a diverse group of engineers and scientists partnering with St. Michael’s Hospital clinicians and researchers, Kolios is using physics to create new methodologies that use ultrasound and optics to image and treat cancer. These methodologies determine the effectiveness of chemotherapy in treating a patient’s cancer while treatment is in its early stages.
Kolios’ research is paving the way for new cancer therapies that minimize damage to surrounding cells and make tumours more sensitive to other forms of treatment. It’s also leading to more efficient and non-invasive ways to monitor treatment effectiveness, so doctors can see how well a patient is responding and make adjustments sooner. Ultimately, these therapies and methods are leading to better treatments and outcomes for people with cancer.
This unique collaboration is transforming the way health professionals and students collaborate.